Biomarker Discovery & Validation
Biomarker discovery and validation in clinical trials are essential for tailoring treatments to individual patients and improving overall trial outcomes. These processes help identify biomarkers that predict disease progression, treatment response, and adverse effects, guiding therapeutic strategies and enhancing trial efficiency. Validated biomarkers ensure reliable and reproducible results, supporting their integration into clinical practice for more precise and effective patient management during trials. This approach accelerates drug development and fosters personalized healthcare approaches within clinical trial settings.
Biomarker Discovery & Validation
Biomarker discovery and validation in clinical trials are essential for tailoring treatments to individual patients and improving overall trial outcomes. These processes help identify biomarkers that predict disease progression, treatment response, and adverse effects, guiding therapeutic strategies and enhancing trial efficiency. Validated biomarkers ensure reliable and reproducible results, supporting their integration into clinical practice for more precise and effective patient management during trials. This approach accelerates drug development and fosters personalized healthcare approaches within clinical trial settings.
Our Expertise
With extensive expertise in genomic and protein analysis for clinical trials, we employ a wide range of cutting-edge technologies for biomarker discovery and validation. This includes Sanger sequencing, qPCR, NGS, ddPCR, ELISA, MSD assays, automated western blotting, and flow cytometry. These capabilities deliver crucial molecular insights, supporting the development of innovative therapies and personalized healthcare solutions. We help our clients for:
- Biomarker Discovery: uncover new biomarkers that can be used for disease detection, diagnosis, prognosis, and treatment monitoring, using state-of-the-art analytical technologies.
- Biomarker Assay Validation: verify that a biomarker assay (test) reliably and accurately measures the biomarker of interest. This includes assessing the assay’s sensitivity, specificity, reproducibility, and accuracy.
- Biomarker Clinical Validation: establish that the biomarker has practical value in a clinical context, such as predicting disease risk, diagnosing a condition, predicting response to treatment, or monitoring disease progression.
Types of Biomarkers
Types
Description
Risk Stratification
Risk stratification biomarkers are essential for preventive medicine.
Disease Screening and Detection
Screening biomarkers are crucial for identifying diseases when they are most treatable.
Diagnostic Biomarkers
Diagnostic biomarkers provide definitive evidence of a disease, aiding in accurate diagnosis.
Prognostic
Prognostic biomarkers help determine disease progression and patient prognosis, regardless of treatment
Predictive
Predictive biomarkers are vital for personalized medicine, guiding treatment choices based on a patient’s likelihood of responding to a particular therapy.
Biomarker Discovery Services
Services
Purpose
Technology
Gene Expression
Identifies gene expression biomarkers for predicting treatment outcomes, monitoring treatment efficacy, and understanding disease pathways.
Genotyping
Used to stratify patients based on genetic profiles and predict their responses to therapies.
- Amplicon Sanger sequencing
- Amplicon NGS
- TaqMan assays
- End-point PCR
Protein Analysis
Identifies protein biomarkers for disease diagnosis, prognosis, and monitoring treatment efficacy.
Metabolomics
Provides insights into metabolic pathways and identifies metabolic biomarkers related to disease and treatment response.
Epigenetic Analysis
Identifies epigenetic biomarkers that can influence gene expression and disease outcomes.
- Chromatin immunoprecipitation (ChIP)
- Methylation-specific PCR
Immunoassays
Identifies immune-related biomarkers for diseases, especially in immunotherapy and infectious diseases.
Cytogenetics
Identifies chromosomal biomarkers related to cancer and genetic disorders.
- Fluorescence in situ hybridization (FISH) (coming soon)
- Karyotyping (coming soon)
Phenotyping
Used for immunophenotyping to identify and classify different cell types, particularly in immunology and oncology, and to assess cellular responses to treatments.
Microbiome Analysis
Identifies microbiome-related biomarkers that can impact health and treatment outcomes.
Single Cell Sequencing
Offer unparalleled insights into the genetic and molecular heterogeneity of biological samples at the single-cell level.
